INITIATE-HFrEF试验的设计,理由和方法:ARNI和SGLT2抑制剂在HFrEF中进行测序
João Pedro Ferreira1, Ana Cristina Oliveira2, Francisca Saraiva2
1RISE-Health, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina, Universidade do Porto, Porto, Portugal; Université de Lorraine, INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm, 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Nancy, France; Serviço de Medicina Interna, Unidade Local de Saúde Gaia/Espinho, Gaia, Portugal.
JACC. Advances
|February 4, 2026
概括
同时开始使用血管激素受体-尼普利辛抑制剂 (ARNi) 和糖共运输体2抑制剂 (SGLT2i) 是安全和有效的,如顺序启动心力衰竭与减少射出分数 (HFrEF). 这一发现支持HFrEF患者的快速指南导向治疗.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- ангиотензин受体-neprilysin抑制剂 (ARNi) 和葡萄糖共运输体2抑制剂 (SGLT2i) 是心力衰竭与减少射出分数 (HFrEF) 的必要疗法.
- 指导方针建议迅速启动ARNi和SGLT2i.
- 没有先前的研究比较了这些药物的同时与顺序启动.
研究的目的:
- 在HFrEF患者中评估ARNi和SGLT2i同时或顺序启动的疗效和安全性.
- 为了确定同时启动是否与顺序启动无差.
主要方法:
- 一个随机的非劣势性试验,比较了两个策略:同时启动 (5天内) 与顺序启动 (4-12周间隔).
- 主要终点:低血压,电解质异常,估计质过率 (eGFR) 显著下降,HF急诊,HF住院或心血管死亡的复合.
- 随访时间大约为24周.
主要成果:
- 六十二名患者被随机分配:29人同时开始,33人顺序开始.
- 基线特征在各组之间得到了良好平衡.
- 该研究满足了其主要终点,证明了同时启动的非劣势性 (复合终点的具体结果在摘要中没有详细说明).
结论:
- 同时启动ARNi和SGLT2i对HFrEF患者的顺序启动没有劣势.
- 这种方法支持快速实施指导方针导向的医学疗法.
- 进一步的研究可能会探索最佳的测序和患者选择同时启动.
更多相关视频
相关概念视频
Initiation of Translation
39.0K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K
Initiation of Translation
8.1K
8.1K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm
424
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
424
Clinical Trials
10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.8K


